REVOLUTION MEDICINES, INC. (RVMD) DISCUSSES FDA APPROVAL OF RASONQUE FOR METASTATIC PANCREATIC CANCER AND IMPLICATIONS FOR RAS-DRIVEN THERAPY TRANSCRIPT - SEEKINGALPHA

FDA approval of Rasonque for metastatic pancreatic cancer marks a pivotal catalyst for RAS-driven therapy.